Skip to main content

Table 3 Health status and adverse effects on complete blood count (CBC), renal and liver function, and fasting blood suger (FBS) tests

From: Sweet-type star fruit supplementation controls oxidative stress status and enhances the community walking capacity among elderly Thai

Parameters

Control

(n=12)

Supplement

(n=11)

Walk Exr.

(n=12)

Supplement + walk Exr.

(n =11)

p*

p#

Before

After

Before

After

Before

After

Before

After

CBC

WBC (103/µL)

5.5 ± 1.2

(5.1-9.5)

5.8 ± 1.0

(4.6-9.5)

5.9 ± 1.5

(5.6-9.2)

6.1 ± 1.1

(5.4-9.9)

5.1 ± 1.1

(4.5-10.2)

5.95 ± 1.3

(5.5-9.7)

6.1 ± 1.5

(5.5-10.6)

6.6 ± 1.2

(4.7-9.0)

0.45

0.38

RBC (106/µL)

4.5 ± 0.5

(3.9-5.1)

4.9 ± 0.9

(4.0-5.2)

4.3 ± 0.2

(3.8-5.6)

4.1 ± 0.2

(3.3-5.2)

4.8 ± 0.2

(4.2-5.0)

4.6 ± 0.3

(4.1-5.0)

4.1 ± 0.3

(3.4-4.8)

4.9 ± 0.7

(3.2-5.3)

0.61

0.51

Hb (g/dL)

13.1 ± 1.4

(11.2-15.5)

12.4 ± 1.5

(10.1-15.2)

15.2 ± 1.8

(10.6-15.8)

14.7 ± 1.4

(11.6-15.1)

12.7 ± 1.3

(10.4-14.0)

13.0 ± 1.2

(10.2-15.0)

13.5 ± 1.6

(12.1-15.2)

14.2 ± 1.3

(11.3-15.3)

0.35

0.52

Hct (%)

41.2 ± 1.5

(35.2-44.5)

44.2 ± 1.3

(36.1-44.2)

39.1 ± 1.2

(36.2-48.0)

41.1 ± 1.1

(35.9-43.2)

39.9 ± 1.2

(36.1-45.2)

40.2 ± 1.5

(37.1-49.5)

39.6 ± 1.2

(36.0-43.2)

44.1 ± 1.0

(35.3-43.1)

0.22

0.34

PLT (103/µL)

235 ± 32.5

(145-345)

241 ± 28.5

(140-325)

256 ± 29.4

(141-410)

230 ± 30.1

(145-399)

225 ±33.2

(139-412)

234 ± 32.5

(141-392)

230 ± 19.3

(144-385)

239 ± 28.5

(140-401)

0.78

0.65

Renal function

BUN (mg/dL)

13.4 ± 0.9

(9.9-18.0)

12.1 ± 0.7

(9.8-16.5)

12.2 ± 0.4

(7.5-16.3)

13.8 ± 0.2

(7.1-6.1)

12.7 ± 1.1

(6.8-16.5)

12.1 ± 0.9

(7.3-16.2)

14.1 ± 0.3

(9.9-18.8)

14.4 ± 1.1

(9.5-16.4)

0.65

0.54

Creatinine (mg/dL)

0.9 ± 0.0

(0.6-1.1)

0.8 ± 0.1

(0.6-1.2)

0.7 ± 0.0

(0.5-1.1)

0.5 ± 0.1

(0.7-1.1)

0.8 ± 0.2

(0.6-1.3)

0.8 ± 0.1

(0.7-1.4)

0.9 ± 0.0

(0.6-1.1)

0.8 ± 0.2

(0.7-1.2)

0.80

0.73

Liver function

AST (U/L)

24.7 ± 2.9

(13-33)

22.7 ± 2.3

(11-31)

26.2 ± 2.2

(15-33)

27.1 ± 2.3

(14-35)

22.8 ± 2.1

(15-29)

21.2 ± 1.9

(16-28)

24.5 ± 2.0

(11-32)

26.2 ± 3.1

(12-30)

0.64

0.55

ALT (U/L)

22.4 ±1.5

(12-31)

20.9 ± 2.1

(11-30)

23.1 ± 2.0

(14-28)

23.8 ± 1.5

(16-31)

20.9 ± 3.4

(10-30)

21.5 ± 2.1

(14-28)

22.3 ± 1.9

(15-27)

25.2 ± 1.5

(10-26)

0.56

0.45

FBS (mg/dL)

91.7 ± 1.2

(78-99)

90.6 ± 2.2

(77-100)

88.2 ± 2.3

(80-98)

92 ± 3.4

(78-99)

96.8 ± 2.3

(77-100)

92.9 ± 1.5

(79-87)

90.1 ± 2.4

(83-100)

94.2 ± 3.2

(70-99)

0.89

0.61

  1. Note: WBC = white blood count, RBC = red blood count, Hb = hemoblogin, Hct = hematocrite, PLT = platelet, BUN = blood urea nitrogen, AST = aspartate transferease, ALT = alanine transferase, FBS = fasting blood suger. * p value was calculated statistically between the four groups at baseline or before, and # p value was calculated statistically between the four groups after completion of the 4-week period with the K-independent Kruskal-Wallkis H test
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us